Search research articles
Contact Us
Filters
Showing results (271-280 of 296) with videos related to
Page
of 30
Sort By:
IJTLD Open
|
January 19, 2026
Conceptualising the experience of having TB: a global qualitative study
D Oberdhan, M Hill, A Gillman, et al.
IJTLD Open
|
January 26, 2026
TB and primary health care: a synergistic pathway to universal health coverage
D Pedrazzoli, F Khalid, F Mavhunga, et al.
IJTLD Open
|
December 15, 2025
The time is now: making the case for compassionate use/pre-approval access to new TB drugs
A Reuter, J Stillo, S S Thi, et al.
IJTLD Open
|
November 17, 2025
Post-TB treatment completion experiences of children, adolescents, and caregivers from Cape Town
C Monin, D T Wademan, C Purdy, et al.
IJTLD Open
|
December 16, 2024
TB survivors: why curing TB is sometimes not enough
E Pontali, R Centis
IJTLD Open
|
January 13, 2025
A year in review - evaluating the launch of IJTLD OPEN
H D Blackbourn, G B Migliori
IJTLD Open
|
January 13, 2025
Children and providers' perspectives on once-weekly rifapentine and isoniazid TB preventive therapy
A J Marthinus, D T Wademan, Z Saule, et al.
IJTLD Open
|
September 20, 2024
Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV
R Borse, B Randive, S Mattoo, et al.
IJTLD Open
|
March 18, 2026
Orbital cellulitis unmasking disseminated TB in a kidney transplant recipient
H Ghabi, R Belaid, S Tlili, et al.
IJTLD Open
|
March 18, 2026
Sustained outcomes 3 years after all-oral 9-month regimen for rifampicin-resistant TB
T M P Nguyen, T H M Le, C S C Merle, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 296) with videos related to
Sort By:
Page
of 30
IJTLD Open
|
January 19, 2026
Conceptualising the experience of having TB: a global qualitative study
D Oberdhan, M Hill, A Gillman, et al.
IJTLD Open
|
January 26, 2026
TB and primary health care: a synergistic pathway to universal health coverage
D Pedrazzoli, F Khalid, F Mavhunga, et al.
IJTLD Open
|
December 15, 2025
The time is now: making the case for compassionate use/pre-approval access to new TB drugs
A Reuter, J Stillo, S S Thi, et al.
IJTLD Open
|
November 17, 2025
Post-TB treatment completion experiences of children, adolescents, and caregivers from Cape Town
C Monin, D T Wademan, C Purdy, et al.
IJTLD Open
|
December 16, 2024
TB survivors: why curing TB is sometimes not enough
E Pontali, R Centis
IJTLD Open
|
January 13, 2025
A year in review - evaluating the launch of IJTLD OPEN
H D Blackbourn, G B Migliori
IJTLD Open
|
January 13, 2025
Children and providers' perspectives on once-weekly rifapentine and isoniazid TB preventive therapy
A J Marthinus, D T Wademan, Z Saule, et al.
IJTLD Open
|
September 20, 2024
Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV
R Borse, B Randive, S Mattoo, et al.
IJTLD Open
|
March 18, 2026
Orbital cellulitis unmasking disseminated TB in a kidney transplant recipient
H Ghabi, R Belaid, S Tlili, et al.
IJTLD Open
|
March 18, 2026
Sustained outcomes 3 years after all-oral 9-month regimen for rifampicin-resistant TB
T M P Nguyen, T H M Le, C S C Merle, et al.
Page
of 30